Fingerprint
Dive into the research topics of 'Pacritinib vs best available therapy, including ruxolitinib, in patients with myelofibrosis: A randomized clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pacritinib vs best available therapy, including ruxolitinib, in patients with myelofibrosis: A randomized clinical trial
John Mascarenhas, Ronald Hoffman, Moshe Talpaz, Aaron T. Gerds, Brady Stein, Vikas Gupta, Anita Szoke, Mark Drummond, Alexander Pristupa, Tanya Granston, Robert Daly, Suliman Al-Fayoumi, Jennifer A. Callahan, Jack W. Singer, Jason Gotlib, Catriona Jamieson, Claire Harrison, Ruben Mesa, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
246
Scopus
citations